1-3 of 3
Neda Nikbakht
Close
Sort by
Journal Articles

Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19

Clinical Trials & Observations
Dolores Grosso, John L. Wagner, Allyson O'Connor, Kaitlyn Keck, Yanping Huang, Zi-Xuan Wang, Hilary Mehler, Benjamin Leiby, Phyllis Flomenberg, Usama Gergis, Neda Nikbakht, Michael Morris, Julie Katz Karp, Alexis Peedin, Neal Flomenberg
Journal: Blood Advances
Blood Adv bloodadvances.2024013344.
https://doi.org/10.1182/bloodadvances.2024013344
Published: 2024
Includes: Supplemental data
Journal Articles

The overlap of skin and blood T-cell clones in early-stage mycosis fungoides

Clinical Trials & Observations
Daniel Joffe, Safiyyah Bhatti, Lauren Banner, Romsin Zaya, Laura Gleason, Anjali Mishra, Ilan Kirsch, Pierluigi Porcu, Neda Nikbakht
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6206–6210.
https://doi.org/10.1182/bloodadvances.2023010867
Published: 2023
Includes: Supplemental data
Journal Articles

Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Colleen Isabelle, William T. Johnson, Kathleen McConnell, Ashley Vogel, Jonathan E. Brammer, Amy Boles, Robyn Keller, Paola Sindaco, Liam Nisenfeld, Guldeep Uppal, Neda Nikbakht, Bruno Calabretta, Patrizia Porazzi, Jerald Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3637–3641.
https://doi.org/10.1182/bloodadvances.2023009807
Published: 2023
Includes: Supplemental data